New York State Common Retirement Fund Forma Therapeutics Holdings, Inc. Transaction History

New York State Common Retirement Fund

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$7.12 - $20.24 $569 - $1,619	80 Added 0.35%	23,036 $460,000
Q2 2022 Aug 04, 2022	SELL	$5.1 - $10.0 $244 - $480	-48 Reduced 0.21%	22,956 $158,000
Q1 2022 May 05, 2022	BUY	$8.34 - $14.69 $208 - $367	25 Added 0.11%	23,004 $214,000
Q4 2021 Feb 02, 2022	SELL	$13.6 - $24.89 $924 - $1,692	-68 Reduced 0.3%	22,979 $327,000
Q3 2021 Nov 02, 2021	SELL	$21.22 - $25.7 $93,325 - $113,028	-4,398 Reduced 16.02%	23,047 $534,000
Q2 2021 Aug 02, 2021	BUY	$22.86 - $30.95 $90,182 - $122,097	3,945 Added 16.79%	27,445 $683,000
Q1 2021 May 11, 2021	BUY	$24.58 - $42.82 $149,938 - $261,202	6,100 Added 35.06%	23,500 $658,000
Q4 2020 Feb 08, 2021	BUY	$34.9 - $51.08 $97,720 - $143,024	2,800 Added 19.18%	17,400 $607,000
Q3 2020 Nov 05, 2020	BUY	$32.95 - $50.25 $481,070 - $733,650	14,600 New	14,600 $728,000

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.